Carulli Michael's most recent trade in PMV Pharmaceuticals Inc was a trade of 28,249 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 01 Jul 2025 | 28,249 | 60,146 | - | 1.1 | 30,077 | Common Stock |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 265,000 | 265,000 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 11 Sep 2024 | 2,891 | 88,395 | - | 1.5 | 4,347 | Common Stock |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 40,805 | 40,805 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 27,200 | 0 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Michael Carulli | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Aug 2024 | 13,605 | 0 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Carulli Michael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 204,630 | 204,630 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Carulli Michael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 82,220 | 91,286 | - | 0 | Common Stock |